Report Detail

Other Global Vaccines Market: Industry Size, Growth, Analysis and Forecast to 2025

  • RnM3557185
  • |
  • 12 July, 2019
  • |
  • Global
  • |
  • 220 pages
  • |
  • DPI Research
  • |
  • Other

Global Vaccines Market: Industry Size, Growth, Analysis and Forecast to 2025

1. ExecutiveSummary

    2. Global Vaccines Market Size & Analysis (2015 – 2025)

      3. Market Share Analysis of Global Vaccines Market (%),2015 – 2025

      • 3.1 Global Vaccines Market Share, By Brand
      • 3.2 Global Vaccines Market Share, By Company

      4. Key Drivers and Inhibitors of the Global Vaccines Market

      • 4.1 Market Drivers
      • 4.2 Market Inhibitors

      5. Global Top 42 Vaccines Market Assessment & Opportunity (Value),2015 – 2025

      • 5.1 Prevnar / Prevnar 13
      • 5.2 Gardasil / Gardasil 9
      • 5.3 Vaxigrip
      • 5.4 Fluzone
      • 5.5 Flublok
      • 5.6 Varivax
      • 5.7 Menactra
      • 5.8 Proquad
      • 5.9 Pneumovax 23
      • 5.10 Fluarix/FluLaval
      • 5.11 Havrix/Twinrix/Engerix–B
      • 5.12 Priorix, Priorix Tetra, Varilrix
      • 5.13 M–M–R II
      • 5.14 Adacel
      • 5.15 Boostrix
      • 5.16 Bexsero
      • 5.17 Menveo
      • 5.18 Cervarix
      • 5.19 Trumenba
      • 5.20 Shingrix
      • 5.21 Pentacel, Pentaxim, Imovax, Hexaxim
      • 5.22 Rotateq
      • 5.23 Zostavax
      • 5.24 Rotarix
      • 5.25 Synflorix
      • 5.26 Pediarix,Infanrix
      • 5.27 Ticovac
      • 5.28 Biken Ha
      • 5.29 Tetrabik
      • 5.30 Mearubik
      • 5.31 Varicella (MTP)
      • 5.32 Jebik V
      • 5.33 Flumist/Fluenz
      • 5.34 Bio Thrax
      • 5.35 Dukoral
      • 5.36 Ixiaro
      • 5.37 In Live
      • 5.38 HeaLive
      • 5.39 BiLive
      • 5.40 Anflu
      • 5.41 EasySix
      • 5.42 Imvamune
      • 5.43 Other Vaccines

      6. Major Deals in Global Vaccines Market

      • 6.1 Merger & Acquisitions
      • 6.2 Collaboration Deal
      • 6.3 Licensing Agreement
      • 6.4 Exclusive Agreement
      • 6.5 Distribution Agreement
      • 6.6 Partnerships

      7. Key Companies Analysis

      • 7.1 Sanofi Pasteur
        • 7.1.1 Business Overview
        • 7.1.2 Vaccines Portfolio
        • 7.1.3 Vaccines Market Value Analysis & Forecast
        • 7.1.4 Promising Vaccines in Clinical Development
        • 7.1.5 Recent Development
      • 7.2 GlaxoSmithKline (GSK)
        • 7.2.1 Business Overview
        • 7.2.2 Vaccines Portfolio
        • 7.2.3 Vaccines Market Value Analysis & Forecast
        • 7.2.4 Promising Vaccines in Clinical Development
        • 7.2.5 Recent Development
      • 7.3 Merck
        • 7.3.1 Business Overview
        • 7.3.2 Vaccines Portfolio
        • 7.3.3 Vaccines Market Value Analysis & Forecast
        • 7.3.4 Promising Vaccines in Clinical Development
        • 7.3.5 Recent Development
      • 7.4 Pfizer
        • 7.4.1 Business Overview
        • 7.4.2 Vaccines Portfolio
        • 7.4.3 Vaccines Market Value Analysis & Forecast
        • 7.4.4 Promising Vaccines in Clinical Development
        • 7.4.5 Recent Development
      • 7.5 AstraZeneca
        • 7.5.1 Business Overview
        • 7.5.2 Vaccines Portfolio
        • 7.5.3 Vaccines Market Value Analysis & Forecast
        • 7.5.4 Recent Development
      • 7.6 Mitsubishi Tanabe Pharma
        • 7.6.1 Business Overview
        • 7.6.2 Vaccines Portfolio
        • 7.6.3 Vaccine Market Value Analysis & Forecast
        • 7.6.4 Promising Vaccines in Clinical Development
        • 7.6.5 Recent Development
      • 7.7 Emergent Biosolutions
        • 7.7.1 Business Overview
        • 7.7.2 Vaccines Portfolio
        • 7.7.3 Vaccine Market Value Analysis & Forecast
        • 7.7.4 Promising Vaccines in Clinical Development
        • 7.7.5 Recent Development
      • 7.8 Astlellas Pharma Inc
        • 7.8.1 Business Overview
        • 7.8.2 Vaccines Portfolio
        • 7.8.3 Vaccines Market Value Analysis & Forecast
        • 7.8.4 Recent Development
      • 7.9 Valneva
        • 7.9.1 Business Overview
        • 7.9.2 Vaccines Portfolio
        • 7.9.3 Vaccines Market Value Analysis & Forecast
        • 7.9.4 Promising Vaccines in Clinical Development
        • 7.9.5 Recent Development
      • 7.10 Seqirus
        • 7.10.1 Business Overview
        • 7.10.2 Vaccines Portfolio
        • 7.10.3 Vaccine Market Value Analysis & Forecast
        • 7.10.4 Promising Vaccines in Clinical Development
        • 7.10.5 Recent Development
      • 7.11 Bavarian Nordic
        • 7.11.1 Business Overview
        • 7.11.2 Vaccines Portfolio
        • 7.11.3 Vaccine Market Value Analysis & Forecast
        • 7.11.4 Promising Vaccines in Clinical Development
        • 7.11.5 Recent Development
      • 7.12 Sinovac
        • 7.12.1 Business Overview
        • 7.12.2 Vaccines Portfolio
        • 7.12.3 Vaccine Market Value Analysis & Forecast
        • 7.12.4 Promising Vaccines in Clinical Development
        • 7.12.5 Recent Development
      • 7.13 Panacea Biotec
        • 7.13.1 Business Overview
        • 7.13.2 Vaccines Portfolio
        • 7.13.3 Vaccine Market Value Analysis & Forecast
        • 7.13.4 Promising Vaccines in Clinical Development
        • 7.13.5 Recent Development
      • 7.14 Bharat Biotech
        • 7.14.1 Business Overview
        • 7.14.2 Vaccines Portfolio
        • 7.14.3 Promising Vaccines in Clinical Development
        • 7.14.4 Recent Development
      • 7.15 Serum Institute of India
        • 7.15.1 Business Overview
        • 7.15.2 Vaccines Portfolio
        • 7.15.3 Promising Vaccines in Clinical Development
        • 7.15.4 Recent Development
      • 7.16 Biological E. Limited
        • 7.16.1 Business Overview
        • 7.16.2 Vaccines Portfolio
        • 7.16.3 Promising Vaccines in Clinical Development

      The global vaccines market size is expected to exceed US$ 48 Billion by the year–end of 2025.

      “Global Vaccines Market: Industry Size, Growth, Analysis and Forecast to 2025” presents an in–depth assessment of the global vaccines market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the most up–to–date industry data on the actual market situation and future outlook for the global vaccines market. The report includes historical data from 2015 to 2018 and forecasts until 2025.

      The report contains a granular analysis of the present industry situations, market demands, reveal facts on the market size, revenues and provides forecasts through 2025. The report provides clear insight into current and future developments of the global vaccines market. The report explores a detailed analysis of the top 42 vaccines market value assessment globally from 2015 to 2018 and forecasts to 2025.

      Additionally, the report includes an assessment of promising vaccines in clinical development by major companies. Key trends in terms of collaboration, merger & acquisitions, partnerships, distribution, exclusive and licensing agreement are analyzed with details. The report also explores the detailed description of growth drivers and inhibitors of the global vaccines market.

      The report concludes with the profiles of major players in the global vaccines market. The key market players are evaluated on various parameters such as business overview, vaccines portfolios, promising vaccines in the clinical development, vaccines market value analysis and recent development.

      Long–term Growth Projection:

      • Merck acquired Immune Design in 2019
      • Shingrix is set to achieve blockbuster vaccine status in 2019
      • Prevnar / Prevnar 13 has captured the highest market share of the global vaccines market
      • With a market value of more than US$ 7 billion, GSK led the global vaccines market in 2018

      Top 42 Vaccines Covered Under This Report Are:

      1. Prevnar / Prevnar 13
      2. Gardasil / Gardasil 9
      3. Vaxigrip
      4. Fluzone
      5. Flublok
      6. Varivax
      7. Menactra
      8. Proquad
      9. Pneumovax 23
      10. Fluarix/FluLaval
      11. Havrix/Twinrix/Engerix–B
      12. Priorix, Priorix Tetra, Varilrix
      13. M–M–R II
      14. Adacel
      15. Boostrix
      16. Bexsero
      17. Menveo
      18. Cervarix
      19. Trumenba
      20. Shingrix
      21. Pentacel, Pentaxim, Imovax, Hexaxim
      22. Rotateq
      23. Zostavax
      24. Rotarix
      25. Synflorix
      26. Pediarix,Infanrix
      27. Ticovac
      28. Biken Ha
      29. Tetrabik
      30. Mearubik
      31. Varicella (MTP)
      32. Jebik V
      33. Flumist/Fluenz
      34. Bio Thrax
      35. Dukoral
      36. Ixiaro
      37. In Live
      38. HeaLive
      39. BiLive
      40. Anflu
      41. EasySix
      42. Imvamune

      The major companies dominating this market for its products, services, and continuous product developments are:

      1. Sanofi Pasteur
      2. GlaxoSmithKline (GSK)
      3. Merck
      4. Pfizer
      5. AstraZeneca
      6. Mitsubishi Tanabe Pharma
      7. Emergent Biosolutions
      8. Astellas Pharma Inc
      9. Valneva
      10. Seqirus
      11. Bavarian Nordic
      12. Sinovac
      13. Panacea Biotec
      14. Bharat Biotech
      15. Serum Institute of India
      16. Biological E. Limited

      The Latest Industry Data Included in this Report:

      • Global Vaccines Market Size & Analysis (2015 – 2025)
      • Market Share Analysis of Global Vaccines Market (%),2015 – 2025
      • Global Vaccines Market Share, By Brand
      • Global Vaccines Market Share, By Company
      • Global Top 42 Vaccines Market Assessment & Opportunity (Value),2015 – 2025
      • Major Companies Vaccines Market Value Analysis & Forecast
      • Promising Vaccines in Clinical Development by Major Companies
      • Detailed Vaccines Portfolio of the Major Companies
      • Major Deals in the Global Vaccines Market
      • Key Market Drivers and Inhibitors of the Global Vaccines Market
      • Major Companies Analysis

      The Report Answers the Following Questions about the Global Vaccines Market:

      • What is the size of the global vaccines market during 2015–2025?
      • What will be the revenue generated by each vaccine during the forecast period?
      • Which vaccine provides the highest market share?
      • What are the leading companies dominating the global vaccines market? What is the share of these companies in the global vaccines market?
      • How will the industry evolve during the forecast period 2019 – 2025?
      • What are the key drivers and inhibitors in the current market?
      • What is the key development implemented by the leading players to stand out in this market?
      • Who are the key players in this market space?


      Summary:
      Get latest Market Research Reports on Vaccines. Industry analysis & Market Report on Vaccines is a syndicated market report, published as Global Vaccines Market: Industry Size, Growth, Analysis and Forecast to 2025. It is complete Research Study and Industry Analysis of Vaccines market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.


      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      $2,190.00
      $2,990.00
      $2,990.00
      1,754.81
      2,395.84
      2,395.84
      1,949.50
      2,661.64
      2,661.64
      236,051.34
      322,280.14
      322,280.14
      150,814.13
      205,906.05
      205,906.05
      Credit card Logo

      Related Reports


      Reason to Buy

      Request for Sample of this report